TARDAJOS AYLLON, Blanca, BOWDEN, Neil, SOUILHOL, Celine, DARWISH, Hazem, TIAN, Siyu, DUCKWORTH, Carrie, PRITCHARD, David Mark, XU, Suowen, SAYERS, Jon, FRANCIS, Sheila, SERBANOVIC-CANIC, Jovana, OAKLEY, Fiona and EVANS, Paul Charles (2025). Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP-p38 and non-canonical NF-κB pathways. Cardiovascular Research, 121 (5), 748-759. [Article]
Documents
36818:1177427
PDF
cvaf024.pdf - Published Version
Available under License Creative Commons Attribution.
cvaf024.pdf - Published Version
Available under License Creative Commons Attribution.
Download (1MB) | Preview
Abstract
Aims
Atherosclerosis initiation at sites of disturbed blood flow involves heightened inflammation coupled to excessive endothelial cell (EC) proliferation. Here, we unveil the pivotal role of c-REL, a member of the NF-κB transcription factor family, in orchestrating these processes by driving dual pathological inflammatory and cell cycle pathways.Methods and results
Analysis of cultured EC and murine models revealed enrichment and activation of c-REL at atherosusceptible sites experiencing disturbed flow. Transcriptome analysis, extensively validated in vitro and in vivo, demonstrates that endothelial c-REL drives inflammation via a TXNIP-p38 MAP kinase signalling pathway and enhances proliferation through a non-canonical NFKB2-p21 pathway. Consistent with its pivotal role in EC pathology, genetic deletion of c-Rel in EC significantly reduces plaque burden in hypercholesterolaemic mice.Conclusion
These findings underscore the fundamental role of c-REL in endothelial responses to disturbed flow and highlight therapeutic targeting of endothelial c-REL as a potential strategy for atherosclerosis treatment.More Information
Statistics
Downloads
Downloads per month over past year
Metrics
Altmetric Badge
Dimensions Badge
Share
Actions (login required)
![]() |
View Item |


Tools
Tools
